|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2006-5-3
|
|
pubmed:abstractText |
Data suggest that vitamin D plays a role in the treatment and prevention of prostate cancer. The combination of high-dose, intermittent calcitriol (1,25 dihydroxyvitamin D3) plus dexamethasone was studied based on evidence that dexamethasone potentiates the antitumor effects of calcitriol and ameliorates hypercalcemia.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright 2006 American Cancer Society
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
106
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2136-42
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:16598750-Aged,
pubmed-meshheading:16598750-Androgens,
pubmed-meshheading:16598750-Calcitriol,
pubmed-meshheading:16598750-Dexamethasone,
pubmed-meshheading:16598750-Dose-Response Relationship, Drug,
pubmed-meshheading:16598750-Drug Administration Schedule,
pubmed-meshheading:16598750-Drug Therapy, Combination,
pubmed-meshheading:16598750-Follow-Up Studies,
pubmed-meshheading:16598750-Humans,
pubmed-meshheading:16598750-Male,
pubmed-meshheading:16598750-Maximum Tolerated Dose,
pubmed-meshheading:16598750-Middle Aged,
pubmed-meshheading:16598750-Neoplasm Staging,
pubmed-meshheading:16598750-Neoplasms, Hormone-Dependent,
pubmed-meshheading:16598750-Patient Selection,
pubmed-meshheading:16598750-Prostatectomy,
pubmed-meshheading:16598750-Prostatic Neoplasms,
pubmed-meshheading:16598750-Risk Assessment,
pubmed-meshheading:16598750-Survival Analysis,
pubmed-meshheading:16598750-Treatment Outcome
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Phase II trial of high-dose, intermittent calcitriol (1,25 dihydroxyvitamin D3) and dexamethasone in androgen-independent prostate cancer.
|
|
pubmed:affiliation |
Department of Medicine, Roswell Park Cancer Institute, Buffalo, New York 14263, USA. donald.trump@roswellpark.org
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase II,
Research Support, N.I.H., Extramural
|
